Bruker, Serva in Proteomic Reagent Co-Marketing Pact

Bruker Daltonics will co-market and sell a labeling reagent for quantitative proteomics for Serva Electrophoresis of Heidelberg, Germany, the companies said this week.

The technology, called Isotope Coded Protein Label, or ICPL, was developed by researchers at the Max-Planck-Institute of Biochemistry in Martinsried, Germany, and is exclusively licensed to Serva. Under the new agreement, Bruker will provide ICPL kits worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.